Prosecution Insights
Last updated: November 04, 2026
Application No. 18/990,378

Inhalation Device Including Substance Usage Control

Non-Final OA §102§103
Filed
Dec 20, 2024
Priority
Aug 24, 2010 — provisional 61/402,136 +5 more
Examiner
LEBRON DE JESUS, GRACIELA NATALIA
Art Unit
3785
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Logic Technology Development LLC
OA Round
1 (Non-Final)
31%
Grant Probability
At Risk
1-2
OA Rounds
1y 7m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants only 31% of cases
31%
Career Allowance Rate
5 granted / 16 resolved
-38.7% vs TC avg
Strong +71% interview lift
Without
With
+70.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
39 currently pending
Career history
64
Total Applications
across all art units

Statute-Specific Performance

§101
10.1%
-29.9% vs TC avg
§103
61.2%
+21.2% vs TC avg
§102
18.1%
-21.9% vs TC avg
§112
7.5%
-32.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 16 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a) the invention was known or used by others in this country, or patented or described in a printed publication in this or a foreign country, before the invention thereof by the applicant for a patent. Claim(s) 1 –20 are rejected under pre-AIA 35 U.S.C. 102(a) as being unpatentable by Brooks et al. (US 4922901 A) Regarding claim 1, An inhalation device comprising: a controller 14 configured to control operation of a heater 18 (Column 4, lines 19 – 23 / Column 5, lines 49 - 54); wherein the controller is configured to turn off the heater 18 when a measured duration of airflow through the inhalation device 10 for each puff reaches or exceeds a limit value (Claim 70). Regarding claim 2, Brooks discloses the inhalation device as claimed in claim 1. Brooks discloses further comprising a timer 112 configured to measure the duration of airflow through the inhalation device 10 for each puff (Column 13, lines 50 – 62). Regarding claim 4, Brooks discloses the inhalation device as claimed in claim 2. Brooks discloses wherein the timer 112 is integrated with the controller 14 (Column 8, lines 15 – 29). Regarding claim 5, Brooks discloses the inhalation device as claimed in claim 1. Brooks discloses further comprising a sensor configured to detect one or more of an airflow, a pressure change. (Column 7, lines 1 – 14) Regarding claim 6, Brooks discloses the inhalation device as claimed in claim 5. Brooks discloses wherein the sensor is at least one of a pressure sensor 28. (Column 7, lines 1 – 14 / Column 11, lines 24 - 40) Regarding claim 7, Brooks discloses the inhalation device as claimed in claim 2. Brooks discloses further comprising a sensor 28 configured to detect one or more of an airflow, a pressure change (Column 7, lines 1 – 14 / Column 11, lines 24 - 40), wherein the timer 112 is configured to be activated by the sensor 28. (Column 11, lines 24 – 53) Regarding claim 8, Brooks discloses the inhalation device as claimed in claim 2. Brooks discloses further comprising a sensor 28 configured to detect one or more of an airflow, a pressure change, wherein the timer 112 measures a puff duration while the sensor is activated. (Column 7, lines 1 – 14 / Column 11, lines 24 - 40), Regarding claim 9, Brooks discloses the inhalation device as claimed in claim 1. Brooks discloses wherein the limit value is set as a total time allowed for airflow through the inhalation device 10 within a given period of use. (Column 13, lines 50 – 62 / Claim 70 / Note: the examiner considers this to be the pulse train including a predetermined duty cycle discloses in claim 70) Regarding claim 10, Brooks discloses the inhalation device as claimed in claim 1. Brooks discloses further comprising a cartridge 12 that contains a substance (Column 3, lines 25 – 31) configured to be released by the heater 18. (Column 8, last paragraph – Column 9, first paragraph) Regarding claim 11, Brooks discloses the inhalation device as claimed in claim 1. Brooks discloses further comprising a cartridge 12 including a heater 18 and a substance configured to be released by the heater 18. (Column 8, last paragraph – Column 9, first paragraph / Column 3, lines 25 – 31) Regarding claim 12, Brooks discloses the inhalation device as claimed in claim 1. Brooks discloses wherein the controller is configured to prevent turning on the heater during a shut off time following the measured duration of airflow reaching or exceeding the limit value. (Column 14, lines 47 – 60 discloses the capacitor which is a part of the controller indirectly turning the heater element on and off by stopping the flow) Regarding claim 13, An inhalation device comprising: a controller 14 configured to control operation of a heater 18 (Column 4, lines 19 – 23 / Column 5, lines 49 - 54); wherein the controller 14 is configured to turn off the heater 18 when a timed airflow through the inhalation device that passes through an inlet hole 54 (Column 7, lines 33 – 47) and an outlet hole (Claim 21) of the device reaches or exceeds a limit value. (Column 11, lines 41 – 53 / Column 14, lines 47 – 60 discloses the capacitor which is a part of the controller indirectly turning the heater element on and off by stopping the flow) Regarding claim 15, Brooks discloses the inhalation device as claimed in claim 13. Brooks discloses further comprising a timer 112 configured to time the airflow through the inhalation device 10 that passes through an inlet hole (Column 7, lines 33 – 47) and an outlet hole (Claim 21) of the device (Column 13, lines 50 – 62), wherein the timer 112 is integrated with the controller 14. (Column 8, lines 15 – 29). Regarding claim 16, Brooks discloses the inhalation device as claimed in claim 13. Brooks discloses further comprising a sensor configured to detect one or more of an airflow, a pressure change. (Column 7, lines 1 – 14) Regarding claim 17, Brooks discloses the inhalation device as claimed in claim 13. Brooks discloses further comprising a sensor 28 configured to detect one or more of an airflow, a pressure change (Column 7, lines 1 – 14 / Column 11, lines 24 - 40) and further comprising a timer 112 configured to time the airflow through the inhalation device 10 that passes through an inlet hole (Column 7, lines 33 – 47) and an outlet hole (Claim 21) of the device (Column 13, lines 50 – 62), wherein the timer 112 is configured to be activated by the sensor 28. (Column 11, lines 24 – 53) Regarding claim 18, Brooks discloses the inhalation device as claimed in claim 13. Brooks discloses further comprising a cartridge 12 that contains a substance (Column 3, lines 25 – 31) configured to be released by the heater 18. (Column 8, last paragraph – Column 9, first paragraph) Regarding claim 19, Brooks discloses the inhalation device as claimed in claim 13. Brooks discloses further comprising a cartridge 12 including a heater 18 and a substance configured to be released by the heater 18. (Column 8, last paragraph – Column 9, first paragraph / Column 3, lines 25 – 31) Regarding claim 20, An inhalation device comprising: a controller 14 configured to control operation of a heater 18 (Column 4, lines 19 – 23 / Column 5, lines 49 - 54); wherein the controller 14 is configured to turn off the heater 18 when an amount of time the heater 18 is activated reaches or exceeds a limit value. (Claim 70) Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 3 is rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Brooks et al. (US 4922901 A) as claimed in claim 1. Regarding claim 3, Brooks discloses the inhalation device as claimed in claim 2. Brooks does not disclose wherein the timer is separate from the controller. Furthermore, since applicants have not disclosed that these modifications solve any stated problem or are for any particular purpose and it appears that the device would perform equally well with either designs, these modifications are a matter of design choice. Absent a teaching as to criticality of the location of the timer woth regards to the controller, this particular arrangement is deemed to have been known by those skilled in the art since the instant specification and evidence of record fail to attribute any significance (novel or unexpected results) to a particular arrangement. In re Kuhle, 526 F.2d 553,555,188 USPQ 7, 9 (CCPA 1975). MPEP 2144.05. Claim 14 is rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Brooks et al. (US 4922901 A) as claimed in claim 13. Regarding claim 14, Brooks discloses the inhalation device as claimed in claim 13. Brooks discloses further comprising a timer 112 configured to time the airflow through the inhalation device 10 that passes through an inlet hole (Column 7, lines 33 – 47) and an outlet hole (Claim 21) of the device. Brooks does not expressly disclose wherein the timer is separate from the controller. Furthermore, since applicants have not disclosed that these modifications solve any stated problem or are for any particular purpose and it appears that the device would perform equally well with either designs, these modifications are a matter of design choice. Absent a teaching as to criticality of the location of the timer with regards to the controller, this particular arrangement is deemed to have been known by those skilled in the art since the instant specification and evidence of record fail to attribute any significance (novel or unexpected results) to a particular arrangement. In re Kuhle, 526 F.2d 553,555,188 USPQ 7, 9 (CCPA 1975). MPEP 2144.05. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to GRACIELA NATALIA LEBRON DE JESUS whose telephone number is (571)270-3892. The examiner can normally be reached Mon - Fri 8:00-5:00 CST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kendra Carter can be reached at 571-272-9034. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /GRACIELA NATALIA LEBRON DE JESUS/Examiner, Art Unit 3785 /KENDRA D CARTER/Supervisory Patent Examiner, Art Unit 3785
Read full office action

Prosecution Timeline

Dec 20, 2024
Application Filed
Oct 29, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741108
INHALER ARTICLE WITH FOLDED DISTAL END
4y 5m to grant Granted Sep 22, 2026
Patent 12629492
CONNECTION COMPONENT FOR A TRACHEAL CANNULA, IN PARTICULAR FOR PROTECTING AGAINST AN UNINTENTIONAL CLOSURE OF SAME
4y 0m to grant Granted May 19, 2026
Patent 12496251
HAND-HELD LOW-NOISE SHOCK-ABSORBING ELECTRIC MASSAGER
3y 8m to grant Granted Dec 16, 2025
Patent 12447091
Headache Treatment Assembly
3y 9m to grant Granted Oct 21, 2025
Patent 12376947
ORAL CAVITY CLEANER FOR AUTOMATICALLY SUCKING CONTAMINATED WATER FOR WASHING ORAL CAVITY
3y 9m to grant Granted Aug 05, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
31%
Grant Probability
99%
With Interview (+70.9%)
3y 6m (~1y 7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 16 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month